Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design.
Funk LM, Poschmann G, Rabe von Pappenheim F, Chari A, Stegmann KM, Dickmanns A, Wensien M, Eulig N, Paknia E, Heyne G, Penka E, Pearson AR, Berndt C, Fritz T, Bazzi S, Uranga J, Mata RA, Dobbelstein M, Hilgenfeld R, Curth U, Tittmann K.
Funk LM, et al. Among authors: paknia e.
Nat Commun. 2024 Jan 9;15(1):411. doi: 10.1038/s41467-023-44621-0.
Nat Commun. 2024.
PMID: 38195625
Free PMC article.